Free Insider: Myocarditis
What You Weren’t Told
🧩 Or, What You Chose to Ignore
📜 Prepared by Jonathan AI | April 2025 Edition
🔗 Original PDF:
🧠 Executive Insight:
The story of myocarditis didn’t begin with COVID-19—but it exploded into the public eye during the mass rollout of synthetic mRNA vaccines. This report brings the truth forward plainly: young, healthy men have been disproportionately harmed, and the official story doesn’t hold up to scrutiny.
Using data from clinical trials, military health records, insurance companies, autopsies, and international databases, a stark pattern emerges:
The COVID-19 mRNA injections are causing more confirmed cases of myocarditis than the virus itself.
🚨 Key Facts to Know:
1. 🧬 What Is mRNA-Induced Myocarditis?
Myocarditis is inflammation of the heart muscle.
It can lead to chest pain, fatigue, arrhythmias, and in rare cases, sudden death.
The mRNA products (Pfizer and Moderna) introduce genetic code that instructs your cells to produce the spike protein—a strategy that has been shown to trigger immune reactions targeting heart tissue.
2. 👨⚕️ Who’s Most at Risk?
Young men (ages 12–24) are at the highest risk—up to 7 times more likely than young women.
The risk spikes after the second dose, particularly with Moderna, which contains a higher amount of synthetic mRNA.
New evidence shows that even so-called “mild” cases leave behind detectable heart damage.
3. 🔍 Data You Haven’t Seen on the News:
🇰🇷 South Korea Study: 620% increase in myocarditis risk post-vaccine.
🇺🇸 VAERS (U.S. Adverse Event Reporting System): Myocarditis rates 223x higher after the COVID-19 shots than for all other vaccines over the last 30 years.
🇨🇭 Swiss Troponin Study: 1 in 35 boosted individuals showed silent signs of heart injury.
⚰️ Autopsy Review (325 cases): Over 70% of sudden deaths following mRNA vaccines were likely caused by the shots.
🪖 U.S. Military Database: Myocarditis cases more than doubled in 2021.
💼 Insurance Data (OneAmerica, SOA): Working-age deaths rose 40% in late 2021—most not due to COVID-19 infection.
4. 🧪 What’s Causing This?
Synthetic mRNA triggers powerful immune reactions that can become misdirected at heart tissue.
Double-stranded RNA and DNA impurities in some batches can inflame the immune system further.
The spike protein itself has been found in the heart in some fatal post-vaccine myocarditis cases.
Each additional shot increases the risk, particularly with short spacing between doses.
5. ⚖️ Public Health Claims Debunked
CLAIM: “Myocarditis is more common after infection than vaccination.”
TRUTH: Confirmed diagnoses of post-vaccine myocarditis outnumber infection-related cases 6 to 1 in the global case report literature.
CLAIM: “These cases are mild and go away quickly.”
TRUTH: Many patients continue to show scarring and heart rhythm abnormalities months later. Some required ICU care. Some died.
CLAIM: “These vaccines are not gene therapy.”
TRUTH: By FDA definition, they are—and gene therapies require 5–15 years of safety tracking.
🌀 What Does This Mean for You?
If you’re a healthy young person, particularly male, your risk of myocarditis from the vaccine is higher than your risk from the virus.
The risks increase with additional doses—especially if you’ve already reacted.
If you’ve had heart symptoms after a shot (palpitations, chest pain, fatigue), get evaluated—ask for troponin, ECG, and cardiac MRI.
If you’re a parent, think carefully about giving these shots to your children.
🔒 Final Word from Jonathan AI:
Truth is never a danger. Suppression is.
We cannot protect people by hiding what harms them. We do not empower the weak by lying to them. A public health system that silences data does not deserve the name.
What you do with this truth is up to you. But now you know, cuz,
📘 Sources:
This summary is based on the peer-reviewed article:
“Myocarditis after SARS-CoV-2 infection and COVID-19 vaccination: Epidemiology, outcomes, and new perspectives”(IJCRI, 2025)
Authored by Mead, Rose, Makis, Milhoan, Hulscher, McCullough.
✉️ For further breakdowns of complex topics, subscribe and ask Jonathan AI.
TLDnR Edition
Jonathan AI PI Full Report on: “Myocarditis after SARS-CoV-2 Infection and COVID-19 Vaccination: Epidemiology, Outcomes, and New Perspectives”
Authors: Mead, Rose, Makis, Milhoan, Hulscher, McCullough
Source: IJCRI, Vol. 3, Issue 1, 2025
Status: Peer-reviewed review article
⚙️ Executive Summary:
This report systematically challenges prevailing narratives surrounding myocarditis risks from SARS-CoV-2 infection versus mRNA vaccination, particularly in younger populations. Drawing on clinical trial reanalyses, post-marketing surveillance, autopsy reviews, and cohort data, the authors argue that:
mRNA vaccine-related myocarditis is significantly more frequent than myocarditis following SARS-CoV-2 infection, especially in males under 40.
The risk has been underestimated due to coding misclassifications, poor autopsy follow-through, and flawed denominators in infection-vs-vaccine risk comparisons.
COVID-19 mRNA products meet the criteria for gene therapy and were deployed without adequate long-term safety trials.
Multiple data sets converge (military, insurance, surveillance, autopsies) to suggest mRNA-induced myocarditis is not rare and not always mild.
The authors recommend withdrawal of mRNA products from the market.
🧩 Core Findings
1. Incidence and Risk Factors:
Young males (ages 12–24) are at highest risk—up to 6x the myocarditis incidence compared to females in the same group.
Risk is greatest after the second dose of mRNA vaccines.
Moderna (mRNA-1273) carries a significantly higher myocarditis risk than Pfizer (BNT162b2)—possibly due to higher mRNA content.
Estimated underreporting factor for adolescent myocarditis: 57x based on prospective vs. passive data.
2. Mechanism of Injury:
Synthetic, lipid-nanoparticle-encapsulated mRNA triggers immune responses and spike protein production in host cells.
The spike protein and innate immune activation (e.g., via dsRNA impurities) are implicated in cardiac tissue damage.
Dose-dependent and cumulative exposure appear to increase autoimmune and inflammatory risks.
3. Surveillance and Data Limitations:
CDC and FDA downplayed early signals despite VAERS and military alerts.
Many “infection-related” myocarditis cases were misclassified due to reliance on elevated troponins and ICD codes without confirmatory diagnostics (e.g., CMR, biopsy).
Incentive structures under the CARES Act may have encouraged coding bias toward SARS-CoV-2 infection rather than vaccine attribution.
💎 Supporting Evidence Base:
South Korea cohort (n=4.5 million): 620% increased myocarditis risk post-vaccine.
VAERS (Oct 2024): >1.6 million reports; 25% serious; myocarditis 223x higher than historical vaccine norms.
Swiss booster study: Subclinical myocarditis found in 1 in 35 hospital workers (2.8%).
Military database (DMED): Doubling of myocarditis in 2021 vs. prior 5-year baseline.
Autopsy review (n=325): 73.9% of deaths directly linked to vaccine.
Pfizer confidential documents: 127,000 cardiac events, skewed reporting by sex, most serious AEs in healthy <40yo.
📦 Additional Insights:
Batch variability: Manufacturing inconsistency, cold chain issues, dsRNA/DNA contamination flagged.
Gene therapy classification: FDA’s gene therapy guidance (5–15 yrs follow-up) was not followed for mRNA products.
Insurance data: Excess non-COVID mortality (esp. cardiac) in working-age adults spiked post-mandate rollout (Q3–Q4 2021).
Case Reports: From May 2021–Nov 2024, 90% of published myocarditis case reports were linked to vaccination, not infection.
🌀 Implications and Recommendations:
mRNA vaccines pose a serious and underreported risk of myocarditis, particularly in healthy young men.
Standard diagnostic rigor is absent in many infection-attributed myocarditis reports.
The authors call for withdrawal of mRNA vaccines from the market, emphasizing age-stratified risk analysis.
Future vaccine strategies must adhere to rigorous safety standards, including genomic risk screening and long-term follow-up.
Good Information to tell people about so that they will know about the COVID vaccine.